Healthcare and Life Science
PhiZ & Co. At RARESummit 2026: Starting a conversation
We're excited to be attending RARESummit 2026 this October, where we'll be exhibiting, meeting new and familiar faces, and running a creative workshop alongside Carina Thurgood, founder of The Maddi Foundation. As we started planning our session, we spent time talki...
Eppendorf introduces the new SpinPro® 8 R high-speed centrifuge
Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the expansion of its centrifuge portfolio with the launch of the new SpinPro 8 R, a refri...
Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy
Novai. a medtech company combatting blindness and disability by pioneering early detection and intervention for eye and brain diseases, today announced the publication of a peer-reviewed study in Expert Review of Ophthalmology1, which successfully demonstrates its ‘Detection of Apoptosi...
What AI in life sciences looks like up close
Reflections from the Cambridge TechBio Caucus working lunch during Cambridge Tech Week. ...
How does lead design affect MRI compatibility?
A smarter way to design MRI-safe implants: Evaluating MRI-induced RF heating earlier with efficient transfer-function modelling ...
The EpiCentre welcomes new cancer diagnostics company 4fold Bioscience
A biotechnology start-up company, developing a low-cost diagnostic platform designed to accurately identify early-stage cancers , has chosen The EpiCentre in Haverhill as the base for its next stage of development ...
Rational VHH Humanisation: Keeping the binder you started with
Isogenica's latest case study shows how a structure-guided, iterative approach to VHH humanisation can push nanobodies to 80%+ human-likeness while retaining antigen binding, expression and stability, avoiding the common pitfall of trading away a good binder's properties in pursuit of s...
Nuclera appoints Carl Raimond as Chief Executive Officer
Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific Co-founder and former CEO Dr Michael Chen transitions to Chief Scientific and Business OfficerCambr...
ROAR Events Agency and Holiday Inn Cambridge launch a summer party partnership for 2027
Cambridge, UK – September 2026 – ROAR Events Agency has announced a new partnership with Holiday Inn Cambridge to deliver a programme of large-scale corporate summer parties and outdoor events throughout May to September 2027. ...
CellCentric wins Business of the Year at 36th Business Weekly Awards ahead of tipped US IPO
Tony Quested writes: CEO Will West winged in from New York as his company CellCentric won the 36th annual Business Weekly Awards' coveted Business of the Year crown at Queens' College. ...